- Home
- CUBA vs DXR Comparison
CUBA vs DXR Comparison
Compare CUBA & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUBA
- DXR
- Stock Information
- Founded
- CUBA 1992
- DXR 1970
- Country
- CUBA United States
- DXR United States
- Employees
- CUBA N/A
- DXR N/A
- Industry
- CUBA Investment Managers
- DXR Medical/Dental Instruments
- Sector
- CUBA Finance
- DXR Health Care
- Exchange
- CUBA Nasdaq
- DXR Nasdaq
- Market Cap
- CUBA 41.2M
- DXR 40.3M
- IPO Year
- CUBA N/A
- DXR N/A
- Fundamental
- Price
- CUBA $2.63
- DXR $8.11
- Analyst Decision
- CUBA
- DXR Strong Buy
- Analyst Count
- CUBA 0
- DXR 1
- Target Price
- CUBA N/A
- DXR $25.00
- AVG Volume (30 Days)
- CUBA 93.9K
- DXR 8.9K
- Earning Date
- CUBA 01-01-0001
- DXR 01-01-0001
- Dividend Yield
- CUBA 20.83%
- DXR N/A
- EPS Growth
- CUBA N/A
- DXR 86.16
- EPS
- CUBA N/A
- DXR 0.11
- Revenue
- CUBA N/A
- DXR $119,714.00
- Revenue This Year
- CUBA N/A
- DXR N/A
- Revenue Next Year
- CUBA N/A
- DXR N/A
- P/E Ratio
- CUBA N/A
- DXR $73.78
- Revenue Growth
- CUBA N/A
- DXR N/A
- 52 Week Low
- CUBA $2.25
- DXR $6.55
- 52 Week High
- CUBA $4.14
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- CUBA 56.74
- DXR 54.46
- Support Level
- CUBA $2.58
- DXR $8.02
- Resistance Level
- CUBA $2.73
- DXR $8.50
- Average True Range (ATR)
- CUBA 0.06
- DXR 0.45
- MACD
- CUBA -0.01
- DXR -0.01
- Stochastic Oscillator
- CUBA 41.18
- DXR 30.77
About CUBA Herzfeld Caribbean Basin Fund Inc. (The)
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.